Company intelligence / Profile preview

Millet Roux

Ownership: Private
Development stage: Other

Overview

Millet Roux was a pioneering pharmaceutical manufacturer founded by French nationals in Brazil in 1918. It was known for producing medications and was succeeded by MR Pharma, which continues its legacy. One documented product is Cyclofemina, an injectable contraceptive containing medroxyprogesterone acetate and estradiol cypionate. No recent clinical results are available.

Therapeutic areas: Women's Health
Modalities: Small molecule
Industry: Biotech

Drug pipeline

3 assets

passiflora

2 more assets in the full pipeline.

Beyond the preview

Go deeper on Millet Roux.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Millet Roux.